Metronidazole
Brand names: Flagyl, Metrolyl
Metronidazole is a nitroimidazole antimicrobial active against anaerobic bacteria and certain protozoa, widely used for anaerobic infections, Clostridioides difficile infection, dental and intra-abdominal infections, and protozoal infections such as giardiasis and trichomoniasis.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
After reductive activation in anaerobic organisms it generates reactive intermediates that damage microbial DNA, leading to strand breakage and cell death.
Prescribing in practice
- A disulfiram-like reaction can occur with alcohol, so patients should avoid alcohol during treatment and for a short period afterwards per the SPC.
- Prolonged or high-dose courses carry a risk of peripheral neuropathy and, rarely, central nervous system effects, so duration should be no longer than necessary.
- It interacts with warfarin and can enhance its anticoagulant effect, so the INR should be monitored when they are used together.
Monitoring
Monitor for neurological symptoms with prolonged courses and check the INR in patients taking warfarin.
Counselling the patient
- Do not drink alcohol while taking this medicine or for a short time after finishing it.
- Complete the full course even if you feel better.
- Report any numbness, tingling or persistent unsteadiness.
Evidence & guidelines
Metronidazole is an established first-line agent for anaerobic and several protozoal infections, supported by long-standing clinical use and guideline recommendation.
Reference: PHE Antibiotic Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections
- Gustilo-Anderson Classification (Open Fractures) · Fracture Classification
- DRIP Score for Drug-Resistant Pneumonia · Pneumonia
- Major Trauma — Primary Survey (ATLS) · ATLS 10th Edition; JRCALC; NICE NG39
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Burns — TBSA Estimation & Fluid Resuscitation · British Burn Association; EMSB; RCEM 2024
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Hypertrophic Pyloric Stenosis · BAPS / RCPCH